期刊文献+

呼吸机相关性肺炎新生儿气管导管末端病原学分析 被引量:4

Tracheal Catheter Tip of Neonatal Ventilator-associated Pneumonia: A Pathogenic Analysis
下载PDF
导出
摘要 目的分析新生儿呼吸机相关性肺炎(VAP)的病原学特点和药物敏感性,为新生儿VAP的临床治疗提供依据。方法选择2009年12月—2012年6月在我院新生儿病房行呼吸机机械通气治疗并确诊为VAP的59例新生儿为研究对象,对气管导管末端的细菌培养结果和药敏试验结果进行回顾性分析。结果 59例新生儿共送检标本62份,55份导管末端细菌培养阳性,阳性率为88.7%。其中革兰阴性杆菌48份(87.3%),革兰阳性菌5份(9.1%),白色念珠菌2份(3.2%),培养阴性7份(11.3%)。55种菌株均有不同程度的药物敏感率及耐药性,革兰阴性杆菌对药物有较好的敏感性,革兰阳性球菌对药物有较大的耐药性。结论新生儿VAP的主要致病菌是以革兰阴性杆菌为主,革兰阳性菌较少见。 Objective To investigate the etiologic features of neonatal ventilator - associated pneumonia (VAP) and its drug sensitivity, to provide a basis for neonatal VAP treatment. Methods A retrospective investigation was done to analyze pathogenic features and drug sensitivity in 59 VAP neonates undergoing treatment of mechanical ventilation from Dec. 2009 to June 2012. Results Totally 62 specimens were sent for check, bacterial culture of 55 cases was positive (88.7%), including 48 cases of Gram -negative bacilli (87. 3% ), 5 Gram - positive bacilli (9. 1% ), 2 canclida albicans (3.2%), 7 negative cuhures ( 11.3% ). Fifty - five strains had different degrees of drug sensitivity and drug resistance, Gram - negative bacilli had good drug sensitivity, while Gram - positive had big drug resistance. Conclusion Gram - negative bacilli are the main patho- gens of neonatal VAP, Gram - positive bacilli is less common.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第26期3128-3130,共3页 Chinese General Practice
基金 2010年徐州市科技发展基金计划项目(XF10C066)
关键词 婴儿 新生 肺炎 呼吸机相关性 导管 留置 病原 药物敏感性测定 Infant, newborn Pneumonia, ventilator - associated Catheter, indwelling Noxae Drug sensitivity assay
  • 相关文献

参考文献16

二级参考文献118

共引文献363

同被引文献61

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2中华医学会重症医学分会.呼吸机相关性肺炎预防、诊断和治疗指南(2013)[J].中华内科杂志,2013,52(6):1.
  • 3Le Conte P, Potel G, Clementi E, et al. Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study [J]. Presse Med, 2000, 29 (2): 76-78.
  • 4Shorr AF, Chan CM, Zilberberg MD. Diagnostics and epidemiology in ventilator - associated pneumonia [ J ]. Ther Adv Respir Dis, 2011, 5 (2): 121-130.
  • 5Bassetti M, Taramasso L, Giacobbe DR, et al. Management of ventilator - associated pneumonia: epidemiology, diagnosis and antimicmbial therapy [J]. Expert Rev Anti Infect Ther, 2012, 10 (5) : 585 -96.
  • 6谢多双,熊薇,来瑞平,等.湖北省重症监护病房中的呼吸机相关性肺炎:一项多中心前瞻性研究[J].医院感染,2011,78(4):284-288.
  • 7Brown RB, Kruse JA, Counts GW, et al. Double - blind study of endotracheal tobramycin in the treatment of gram - negative bacterial pneumonia [ J ]. Antimicrob Agents Chemother, 1990, 34 ( 2 ) : 269 - 272.
  • 8Hallal A, Cohn SM, Namias N, et al. Aerosolized tobramycin in the treatment of ventilator - associated pneumonia: a pilot study [ J ]. Surg Infect (Larchmt), 2007, 8 (1) : 73 -82.
  • 9Rattananmpawan P, Lorsutthitham J, Ungprasert P, et al. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator - associated pneumonia caused by Gram - negative bacteria [ J ]. J Antimicrob Chemother, 2010, 65 (12): 2645-2649.
  • 10Lu Q, Yang J, Liu Z, et al. Nebulized eeftazidime and amikaein in ventilator- associated pneumonia caused by Pseudomonas aeruginosa [J]. Am J Respir Crit Care Med, 2011, 184 (1) : 106 -115.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部